Project Details
| Status | Active |
|---|---|
| Effective start/end date | 9/01/25 → 8/01/30 |
Clinical Trial Phase
- Phase III (a & b)
A global phase 3, randomised, double-blind and placebo-controlled study evaluating the efficacy and safety of etavopivat in adolescents and adults with sickle cell disease. Hibiscus 2
- Kaplan, Zane (Primary Chief Investigator (PCI))
Project: Research